Gene therapy for heart failure

Yang, 1994, Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy, Proc Natl Acad Sci U S A, 91, 4407, 10.1073/pnas.91.10.4407 Guzman, 1993, Efficient gene transfer into myocardium by direct injection of adenovirus vectors, Circ Res, 73, 1202, 10.1161/01.RES.73.6.1202 Calabrese, 2003, Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects, Cardiovasc Res, 60, 11, 10.1016/S0008-6363(03)00475-9 Vorburger, 2002, Adenoviral gene therapy, Oncologist, 7, 46, 10.1634/theoncologist.7-1-46 Miyoshi, 1998, Development of a self-inactivating lentivirus vector, J Virol, 72, 8150, 10.1128/JVI.72.10.8150-8157.1998 Palomeque, 2007, Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo, Gene Ther, 14, 989, 10.1038/sj.gt.3302895 McCarty, 2004, Integration of adeno-associated virus (AAV) and recombinant AAV vectors, Annu Rev Genet, 38, 819, 10.1146/annurev.genet.37.110801.143717 Chu, 2003, Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors, J Thorac Cardiovasc Surg, 126, 671, 10.1016/S0022-5223(03)00082-5 Murphy, 2009, Diverse IgG subclass responses to adeno-associated virus infection and vector administration, J Med Virol, 81, 65, 10.1002/jmv.21360 Peden, 2004, Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain, J Virol, 78, 6344, 10.1128/JVI.78.12.6344-6359.2004 Carter, 2005, Adeno-associated virus vectors in clinical trials, Hum Gene Ther, 16, 541, 10.1089/hum.2005.16.541 Lai, 2000, Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity, Circulation, 102, 2396, 10.1161/01.CIR.102.19.2396 Hayase, 2005, Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade, Am J Physiol Heart Circ Physiol, 288, H2995, 10.1152/ajpheart.00703.2004 Preovolos, 2006, Development of a novel perfusion technique to allow targeted delivery of gene therapy--the V-Focus system, J Extra Corpor Technol, 38, 51 Raake, 2008, Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors, Gene Ther, 15, 12, 10.1038/sj.gt.3303035 Smits, 2002, Efficacy of percutaneous intramyocardial injections using a nonfluoroscopic 3-D mapping based catheter system, Cardiovasc Drugs Ther, 16, 527, 10.1023/A:1022902819844 Kornowski, 2000, Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy Results in normal and ischemic porcine models, J Am Coll Cardiol, 35, 1031, 10.1016/S0735-1097(99)00642-7 Anderl, 2009, Retention and biodistribution of microspheres injected into ischemic myocardium, J Biomed Mater Res A, 88, 704, 10.1002/jbm.a.31917 Vassalli, 2003, Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors, Int J Cardiol, 90, 229, 10.1016/S0167-5273(02)00554-5 Hou, 2003, A novel percutaneous technique for accessing the normal pericardium: a single-center successful experience of 53 porcine procedures, J Invasive Cardiol, 15, 13 Engelhardt, 2001, Constitutive activity of the human beta(1)-adrenergic receptor in beta(1)-receptor transgenic mice, Mol Pharmacol, 60, 712 Milano, 1994, Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor, Science, 264, 582, 10.1126/science.8160017 Liggett, 2000, Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level, Circulation, 101, 1707, 10.1161/01.CIR.101.14.1707 Maurice, 1999, Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery, J Clin Invest, 104, 21, 10.1172/JCI6026 Shah, 2000, Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart: prospects for molecular ventricular assistance, Circulation, 101, 408, 10.1161/01.CIR.101.4.408 Hata, 2004, Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization, J Mol Cell Cardiol, 37, 11, 10.1016/j.yjmcc.2004.03.014 Raake, 2008, G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure, Circ Res, 103, 413, 10.1161/CIRCRESAHA.107.168336 Shah, 2001, In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction, Circulation, 103, 1311, 10.1161/01.CIR.103.9.1311 Gao, 1999, Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice, Circulation, 99, 1618, 10.1161/01.CIR.99.12.1618 Iwase, 1997, Cardiomyopathy induced by cardiac Gs alpha overexpression, Am J Physiol, 272, H585 Engelhardt, 1999, Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice, Proc Natl Acad Sci U S A, 96, 7059, 10.1073/pnas.96.12.7059 Takahashi, 2006, Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction, Circulation, 114, 388, 10.1161/CIRCULATIONAHA.106.632513 Lai, 2004, Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure, Circulation, 110, 330, 10.1161/01.CIR.0000136033.21777.4D Hammond, 2006, Adenylyl cyclase gene transfer in heart failure, Ann N Y Acad Sci, 1080, 426, 10.1196/annals.1380.032 Bers, 2000, Calcium fluxes involved in control of cardiac myocyte contraction, Circ Res, 87, 275, 10.1161/01.RES.87.4.275 Kranias, 1986, A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum, J Biol Chem, 261, 10029, 10.1016/S0021-9258(18)67485-X Pathak, 2005, Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1, Circ Res, 96, 756, 10.1161/01.RES.0000161256.85833.fa Zarain-Herzberg, 1996, Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction, Mol Cell Biochem, 163-164, 285, 10.1007/BF00408669 Sakata, 2006, Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer, Mol Ther, 13, 987, 10.1016/j.ymthe.2006.01.002 Kawase, 2008, Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure, J Am Coll Cardiol, 51, 1112, 10.1016/j.jacc.2007.12.014 Kaye, 2007, Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals, J Am Coll Cardiol, 50, 253, 10.1016/j.jacc.2007.03.047 del Monte, 2002, Targeting phospholamban by gene transfer in human heart failure, Circulation, 105, 904, 10.1161/hc0802.105564 Suckau, 2009, Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy, Circulation, 119, 1241, 10.1161/CIRCULATIONAHA.108.783852 Bartel, 1996, Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts, Mol Cell Biochem, 157, 171, 10.1007/BF00227896 Carr, 2002, Type 1 phosphatase, a negative regulator of cardiac function, Mol Cell Biol, 22, 4124, 10.1128/MCB.22.12.4124-4135.2002 Nicolaou, 2009, Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury, Circ Res, 104, 1012, 10.1161/CIRCRESAHA.108.189811 Du, 2002, Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice, Mol Cell Biol, 22, 2821, 10.1128/MCB.22.8.2821-2829.2002 Pleger, 2007, Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue, Circulation, 115, 2506, 10.1161/CIRCULATIONAHA.106.671701 Brocheriou, 2000, Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury, J Gene Med, 2, 326, 10.1002/1521-2254(200009/10)2:5<326::AID-JGM133>3.0.CO;2-1 Most, 2003, Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2), J Biol Chem, 278, 48404, 10.1074/jbc.M308587200 Communal, 1999, Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein, Circulation, 100, 2210, 10.1161/01.CIR.100.22.2210 Zhu, 2001, Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes, Proc Natl Acad Sci U S A, 98, 1607, 10.1073/pnas.98.4.1607 Rodriguez, 2005, Apoptosis: measurement and technical issues, J Mol Cell Cardiol, 38, 15, 10.1016/j.yjmcc.2004.11.002 Jaski, 2009, Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial, J Card Fail, 15, 171, 10.1016/j.cardfail.2009.01.013